RecruitingPhase 1NCT05322213

THC Effects on Glucose in Type 2 Diabetes

The Effects of THC on Glucose Metabolism and Endothelial Function in Subjects With Type 2 Diabetes


Sponsor

University of California, San Diego

Enrollment

30 participants

Start Date

Aug 22, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study will examine the effects THC has on Glucose Metabolism and Endothelial Functioning in participants with Type 2 Diabetes. The participants will complete blood tests and tests to measure energy expenditure, CVD risks, and glucose metabolism. These tests will be performed prior to start of treatment and again after 2-weeks of treatment with the THC or placebo.


Eligibility

Min Age: 21 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study investigates how THC (the active ingredient in cannabis/marijuana) affects blood sugar levels in people with Type 2 diabetes, to better understand whether cannabis use has meaningful effects on glucose control. **You may be eligible if...** - You have been diagnosed with Type 2 diabetes - You are 21 or older - You are willing to use a controlled dose of THC under supervision during the study **You may NOT be eligible if...** - You have Type 1 diabetes - You are pregnant or breastfeeding - You have a history of psychosis or cannabis use disorder - You use insulin Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTHC

2-Week, once daily, flexible dose, inhaled THC

DRUGPlacebo

2-Week, once daily, flexible dose, inhaled placebo


Locations(1)

UC San Diego Altman Clinical & Translational Research Institute

La Jolla, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05322213


Related Trials